SEC Form 4/A · accession 0001209191-18-009446
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lewis T Williams
Officer — Executive Chairman · Director
Period of report
Sep 1, 2016
Accepted (ET)
Feb 13, 2018 · 11:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2016 | F | 32,613 | $44.74 | D | 431,715 | D | |
| Common StockF2 | Sep 1, 2016 | G | 22,416 | $0.00 | D | 409,299 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to reflect the correct disposition of shares of common stock by the reporting person in satisfaction of a tax liability on September 1, 2016. The original Form 4 filed with the Securities and Exchange Commission on September 1, 2016 inadvertently included a disposal of 7,613 shares of common stock rather than 32,613 shares of common stock, as shown in this amendment.
- F2This amendment reflects that the reporting person's gift of 22,416 shares of common stock reported in the original Form 4 filed with the Securities and Exchange Commission on September 1, 2016 was not a market transaction and as such, no price is reported in this amendment. The reporting person did not receive any value for the gifted shares.